|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-9-12
|
|
pubmed:abstractText |
Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease (ESRD) in HIV-infected patients. Angiotensin-converting enzyme (ACE) inhibition has previously shown a short-term benefit in HIVAN. This study examines the long-term effects of ACE inhibition on renal survival in HIVAN.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0085-2538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1462-71
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12969167-AIDS-Associated Nephropathy,
pubmed-meshheading:12969167-Adult,
pubmed-meshheading:12969167-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12969167-Anti-Retroviral Agents,
pubmed-meshheading:12969167-Cohort Studies,
pubmed-meshheading:12969167-Female,
pubmed-meshheading:12969167-Fosinopril,
pubmed-meshheading:12969167-Humans,
pubmed-meshheading:12969167-Kidney Failure, Chronic,
pubmed-meshheading:12969167-Male,
pubmed-meshheading:12969167-Middle Aged,
pubmed-meshheading:12969167-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.
|
|
pubmed:affiliation |
Department of Medicine, Saint Vincent's Hospital and Medical Center, New York, New York 10011, USA. alice.ei@att.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
